Learning Objectives:
1. Provide an update to the original definition and classification of dystonia to facilitate its clinical recognition and management
2. Discuss the relevance, specificity, and sensitivity of recently identified fluid and neuroimaging biomarkers focused on parkinsonisms and Huntington‘s disease
3. Identify new techniques, indications, and targets for neuromodulation